About the Vision Care Market
Uncorrected refractive errors are the main cause of severe and moderate visual impairment, while eye conditions such as pink eye and cataracts (non-refractive errors) are the leading causes of blindness in middle- and low-income countries.
The governments in many countries have introduced national programs and regulations to control and prevent visual impairment. Eye care services are easily available and are progressively being integrated into primary and secondary healthcare systems, which focus on the provision of high-quality services at affordable prices. For instance, Brazil has been providing eye care services through the inational social security system since 2004, Morocco has been following up with the inational Blindness Control Program since 1991, China has invested over 100 million dollars on cataract surgeries since 2009, the Indian government has made provisions for funds for the poorest people at the district levels since 1995, and the Oman government offers integrated eye care services in its primary health care framework.
Technavio’s analysts forecast the global vision care market to grow at a CAGR of 3.83% during the period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global vision care market for 2016-2020. To calculate the market size, we use the revenue generated from the sale of various types of vision care products.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Vision Care Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the operating in this market.
Key vendors
• Cooper
• Essilor
• Johnson & Johnson
• Luxottica
• Novartis
• Valeant Pharmaceuticals
Other prominent vendors
• All Pro Intraocular Lens
• Blanchard
• CHEMIGLAS
• Fielmann
• Hongchen Optical
• Hoya
• Menicon
• Rodenstock
• Seiko Group
• Shanghai Conant Optics
• Synergeyes
• UltraVision
• Wesley Jessen
Market driver
• Increased brand-consciousness among patients
• For a full, detailed list, view our report
Market challenge
• Production challenges
• For a full, detailed list, view our report
Market trend
• Introduction of innovative contact lenses
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
PART 05: Market landscape
• Market overview
• Five forces analysis
• Global vision care market by product
• Global glass lens market
• Global contact lens market
• Global intraocular lens market
• Global contact solution market
• Global LASIK equipment market
• Global artificial tear market
PART 06: Geographical segmentation
• Global vision care market by geography
• Vision care market in Americas
• Vision care market in Europe
• Vision care market in APAC
• Vision care market in MEA
PART 07: Market drivers
PART 08: Impact of drivers
PART 09: Market challenges
PART 10: Impact of drivers and challenges
PART 11: Market trends
PART 12: Vendor landscape
• Competitive scenario
• Industry associations
• Key vendor analysis
• Cooper
• Essilor
• Johnson & Johnson
• Luxottica
• Novartis
• Valeant Pharmaceuticals
• Other prominent vendors
PART 13: Appendix
• List of abbreviations
PART 14: Explore Technavio
List of Exhibits
Exhibit 01: Product offerings
Exhibit 02: Types of refractive and non-refractive errors
Exhibit 03: Global vision care market 2015-2020 ($ billions)
Exhibit 04: Five forces analysis
Exhibit 05: Global vision care market by product 2015-2020 ($ billions)
Exhibit 06: Global vision care market by product 2015-2020 (% share)
Exhibit 07: Global glass lens market 2015-2020 ($ billions)
Exhibit 08: Global glass lens market by product type 2015 and 2020 (% share)
Exhibit 09: Global glass lens market by geography 2015 and 2020 (% share)
Exhibit 10: Global contact lens market 2015-2020 ($ billions)
Exhibit 11: Global contact lens market by product 2015 and 2020 (% share)
Exhibit 12: Global contact lens market by application 2015 and 2020 (% share)
Exhibit 13: Global contact lens market by geography 2015 and 2020 (% share)
Exhibit 14: Market share and YoY growth for types of soft lens 2016-2020
Exhibit 15: Global intraocular lens market 2015-2020 ($ billions)
Exhibit 16: Number of cataract procedures performed worldwide (millions)
Exhibit 17: Prominent players in the intraocular lens market 2015
Exhibit 18: Global contact solution market 2015-2020 ($ billions)
Exhibit 19: Global LASIK equipment market 2015-2020 ($ millions)
Exhibit 20: Number of eyes treated with LASIK 2014-2020 (thousands)
Exhibit 21: Global artificial tear market 2015-2020 ($ millions)
Exhibit 22: Global vision care market by geography 2015-2020 ($ billions)
Exhibit 23: Global vision care market by geography 2015-2020 (% share)
Exhibit 24: Vision care market in Americas 2015-2020 ($ billion)
Exhibit 25: Percentage of Americans with low vision or vision loss by age 2015
Exhibit 26: Vision care market in Europe 2015-2020 ($ billion)
Exhibit 27: Vision care market in APAC 2015-2020 ($ billion)
Exhibit 28: Vision care market in MEA 2015-2020 ($ billion)
Exhibit 29: Prevalence of eye diseases in US 2015
Exhibit 30: Impact of drivers
Exhibit 31: Impact of drivers and challenges
Exhibit 32: Comparison of risk of infection
Exhibit 33: Cooper: Key takeaways
Exhibit 34: Essilor: Key takeaways
Exhibit 35: Johnson & Johnson: Key takeaways
Exhibit 36: Luxottica: Key takeaways
Exhibit 37: Novartis: Key takeaways
Exhibit 38: Valeant Pharmaceuticals: Key takeaways
